Navigation Links
U of T-led study cracks universal RNA code, suggests a new cause for autism
Date:7/12/2013

The discovery cracks the "RNA control code," which dictates how RNA a family of molecules that mediates DNA expression moves genetic information from DNA to create proteins.

"For the first time, we understand the language of a code that is essential to gene processing," said Quaid Morris, a Professor in U of T's Donnelly Centre for Cellular and Biomolecular Research and the Banting and Best Department of Medical Research. "Many human diseases are due to defects in this code, so figuring out what it means is crucial to creating new treatments for many conditions."

The scientific journal Nature published the study results in its July 11, 2013 issue.

The researchers translated the code with a biochemical technique developed by a research scientist in Hughes' lab, Debashish Ray, and a student in Morris's lab, Hilal Kazan. The team defined the meaning of "words" in RNA, allowing identification of patterns in RNA molecules that proteins use to control RNA processing and movement, which are often altered in disease.

One protein they looked at may explain some of the symptoms in children with autism. The researchers found that RBFOX1, a protein often turned off in the brains of patients, ensures the activity of genes important for the function of nerve cells in the brain.

"This was a surprising finding, because we knew RBFOX1 controls gene expression, but had no idea it also stabilizes RNA," said Tim Hughes, a Professor in the Department of Molecular Genetics and the Donnelly Centre. "It's a good example of the predictive power of the RNA control code, which we think will really open up the field of gene regulation."

Hughes said the work also shows that the RNA control code may be easier to interpret than a similar control code in DNA. Researchers have been struggling for years to understand this DNA control code, but the new results suggest RNA control could offer a more fruitful area of inquiry, with aut
'/>"/>

Contact: Jim Oldfield
jim.oldfield@utoronto.ca
416-946-8423
University of Toronto
Source:Eurekalert

Page: 1 2

Related biology news :

1. Vanderbilt-led team to develop microbrain to improve drug testing
2. Study finds surprising benefits about diary cow inflammation
3. Metastatic pancreatic, primary breast cancer have common growth mechanisms, study suggests
4. Journal highlights Arctic sea ice study by UM professor
5. Innovative MIT study estimates extent to which air pollution in China shortens human lives
6. Temperature increases causing tropical forests to blossom, according to study
7. New study reveals important role of insulin in making breast milk
8. Study reveals ancient jigsaw puzzle of past supercontinent
9. Reproductive BioMedicine Online publishes study on assisted reproduction
10. Lifesaving HIV treatment could reach millions more people following landmark study
11. Low levels of toxic proteins linked to brain diseases, study suggests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, a ... start of a new Phase III double blind, randomized, ... novel formulation, CM-AT, on all children ages 3-8 with ... FDA Phase III double blinded clinical trial for CM-AT ... levels of the digestive enzyme chymotrypsin. This new trial ...
(Date:5/6/2015)... AVIV, Israel , May 6, 2015 ... world,s most established helmet producer, announced today that they ... Smart Helmet, the world,s first bio-sensing cycling helmet and ... be released in two new colors in order to ... for the product. In addition, LifeBEAM and Lazer announced ...
(Date:4/27/2015)... Fla. , Apr. 27, 2015 Profile ... access control and security systems is pleased to announce ... company as a consultant and member of its scientific ... is widely known as a thought leader in technology-enhanced ... Learning Technology Group, and has published studies and books ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... Emory University School of Medicine have obtained a detailed ... key immune system genes. The finding could help ... drugs with fewer side effects. The results are ... Nature Structural & Molecular Biology . Synthetic ...
... du Sud, 7 décembre 2012 Integrated Biometrics, ... technologique grâce à la certification par le FBI ... développement d,IB a créé un nouveau produit en ... Sensor (LES) ainsi qu,à un transistor en couches ...
... humans interbreed and produce offspring of mixed ancestry? ... with anatomically modern humans tens of thousands of years ... human gene pool. But the findings are not universally ... clarify the role of interbreeding, which is also known ...
Cached Biology News:Steroid hormone receptor prefers working alone to shut off immune system genes 2Integrated Biometrics présente Sherlock, le capteur d'empreintes digitales le plus léger, le plus mince et le plus petit, certifié conformément à l'Annexe F Mobile ID 2Monkey business: What howler monkeys can tell us about the role of interbreeding in human evolution 2Monkey business: What howler monkeys can tell us about the role of interbreeding in human evolution 3
(Date:5/26/2015)... Just the characterization of being a new ... does not guarantee immediate acceptance. In particular, a ... prior failures is often met with significant skepticism. ... irony that is often an unappreciated aspect of scientific ... Asymmetrex has found that building acceptance of its ...
(Date:5/22/2015)... DUBLIN , May 22, 2015  Actavis plc ... of the U.S. Court of Appeals for the Second ... 2014 preliminary injunction requiring the Company to continue distribution ... Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO   ... uphold this ruling, we intend to continue our strong ...
(Date:5/21/2015)... 21, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... that develops and commercializes proprietary technologies and products for ... results for the second fiscal quarter ended March 31, ... continued to advance business with our existing customers and ... President and CEO of SQI. "The delivery of a ...
(Date:5/21/2015)... San Francisco, CA (PRWEB) May 21, 2015 ... microbiome sequencing, has announced a partnership with PicnicHealth, ... records for patients. Participants diagnosed with Inflammatory Bowel ... as well as a complementary uBiome research kit. ... Summer 2014. , For more ...
Breaking Biology Technology:In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 2In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8SQI Diagnostics Reports Second Quarter Financial Results 2SQI Diagnostics Reports Second Quarter Financial Results 3SQI Diagnostics Reports Second Quarter Financial Results 4SQI Diagnostics Reports Second Quarter Financial Results 5SQI Diagnostics Reports Second Quarter Financial Results 6SQI Diagnostics Reports Second Quarter Financial Results 7SQI Diagnostics Reports Second Quarter Financial Results 8uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3
... In an address to,shareholders at the company,s annual ... Chairman and CEO David B. Snow Jr. today ... to deliver strong,continuing earnings growth through 2008 and ... pharmacy to retaining and winning,customers, and advanced clinical ...
... Detects Extravasations during CT ... Contrast ... today,that its XDS(TM) Extravasation Detector has received a 2008 Medical ... in the,detection of leaking intravenous contrast media from the injection ...
... 22 Nektar,Therapeutics (Nasdaq: NKTR ) announced ... Company as Chief Operating Officer and Head of ... all aspects of the PEGylation Business Unit, including ... Company. He will also,serve as Chairman of Nektar ...
Cached Biology Technology:Medco CEO to Shareholders: Delivering Results, Driving Shareholder Value 2Medco CEO to Shareholders: Delivering Results, Driving Shareholder Value 3Medco CEO to Shareholders: Delivering Results, Driving Shareholder Value 4MEDRAD(R) XDS(TM) Extravasation Detector Wins Medical Design Excellence Award 2MEDRAD(R) XDS(TM) Extravasation Detector Wins Medical Design Excellence Award 3Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit 2Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit 3
Request Info...
...
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: